Picture of Longeveron logo

LGVN — Longeveron News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Longeveron Granted Canadian Patent For Method Of Using Stem Cells To Treat Non-Ischemic Dilated Cardiomyopathy

Dec 2 (Reuters) - Longeveron Inc LGVN.O:

LONGEVERON GRANTED CANADIAN PATENT FOR METHOD OF USING STEM CELLS TO TREAT NON-ISCHEMIC DILATED CARDIOMYOPATHY AND AGING-RELATED FRAILTY IN PATIENTS WITH INFLAMMAGING

Source text: ID:nGNX1wJC31

Further company coverage: LGVN.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Longeveron

See all news